中銀香港(02388.HK):累計向逾7,000家中小企合共批出超過500億元貸款
中銀香港(02388.HK)工商金融部總經理謝小玲表示,該行一直致力協助本地中小企應對疫情挑戰,並會全力配合及支持金管局與「銀行業中小企貸款協調機制」延長「預先批核還息不還本」計劃,以及香港按證保險有限公司延長「中小企融資擔保計劃」延遲償還本金的安排,以紓緩中小企的資金壓力。
她指出,該行今年初因應疫情發展進一步加大抗疫防疫金融服務支持力度,為中小企投入500億元的信貸資源,截至今年8月底已向超過7,000家中小企合共批出超過500億元的貸款,覆蓋貿易、零售、建造、飲食及服務等行業,未來亦將持續透過一系列金融支持措施及數字化銀行服務,與中小企攜手迎接疫情後經濟復甦 的機遇。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.